Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Encephalitis is a worldwide public health issue, with a substantially high burden among children in Southeast Asia. A large study of the causes of childhood encephalitis in SE Asia suggests that enhanced and effective vaccination against the Japanese encephalitis virus alone could reduce encephalitis prevalence by one third.

Group photo of the SEAe KOM ceremony

Published in Lancet Global Health, the study was conducted by the South-East Asia encephalitis (SEAe) project, a global collaboration coordinated by the Institut Pasteur (Paris), with partners in hospitals in the Lao PDR, Cambodia, Viet Nam and Myanmar and diverse reference laboratories.

The Lao site was coordinated by the MORU Tropical Health Network’s Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU), embedded within the Microbiology Laboratory of Mahosot Hospital in Vientiane. A harmonised diagnostic system was used at Mahosot Hospital and elsewhere that allowed diagnosis of 23 treatable and key pathogens within 24 hours of patient admission.

"The high morbidity and mortality in conjunction with the high proportion of vaccine-preventable infections emphasises the enormous importance of enhanced vaccine coverage across Asia, of accessible evidence-based lab diagnostic strategies given the inaccuracies of clinical aetiological diagnosis, and appropriate and urgent empirical treatment, said Dr Sayaphet Rattanavong, research physician for the project in LOMWRU".

Encephalitis is inflammation that can result from a brain parenchyma infection, the functional tissue of the brain, or as a result of autoimmune response. It is a worldwide public health concern because of its high mortality rate and the neurological sequelae it causes. However, its causes often remain unknown. Viruses are the most frequent in case of infection but other pathogens may be responsible.  importantly, the study demonstrated the importance of prevention as well as rapid and appropriate diagnosis and treatment of patients suffering from encephalitis.

Of 694 children included in the SEAe study, 664 had encephalitis. A cause was identified in 64% of cases. The most common cause was Japanese encephalitis virus infection (33% of patients). The scientists also identified cases associated with dengue virus infection, influenza, herpes simplex virus 1, Mycobacterium tuberculosis, pneumococcus, enterovirus 71, other infectious agents (with more than 30 pathogens identified), and autoimmunity. Of all the causes identified, 18% were treatable and 42% could have been prevented by vaccination.

By the end of their hospital stay, 13% of the children had died, 23% had severe neurological sequelae, 30% had slight or moderate neurological sequelae, and 34% no sequelae. The risk factors for death or severe neurologic sequelae were related to meningeal tuberculosis, the presence of respiratory failure with oxygen requirements, the presence of prolonged coma, and delayed care.

"The data generated by this study will help in the development of diagnostic and preventive management recommendations for encephalitis in the Greater Mekong Region. They underline the importance of national mass vaccination campaigns targeting the Japanese encephalitis virus," said Marc Lecuit, (Université Paris Cité and Hôpital Necker-Enfants malades AP-HP), head of the Infection Biology Unit at the Institut Pasteur (Université Paris Cité, Inserm) and co-coordinator of the study.

Read the publication 'Childhood encephalitis in the Greater Mekong region (the SouthEast Asia Encephalitis Project): a multicentre prospective study' on The Lancet website.

About the South East Asia encephalitis (SEAe) Consortium 

The South East Asia Encephalitis (SEAe) Consortium brings together physicians and researchers from Europe and countries affected by childhood encephalitis in South-East Asia. It brings together a number of complementary partners with the aim of addressing some of the most important issues currently raised by encephalitis (including meningoencephalitis) in South-East Asia.

Similar stories

MORU hepatitis work focusses on preventing mother-to-child transmission, high-at-risk populations, and remote communities

MORU Tropical Health Network researchers in Southeast Asia study various aspects of hepatitis B and C, infections that can lead to chronic liver diseases, and complications like liver cancer or cirrhosis. Researchers at MOCRU work on treatment for hepatitis C, a frequent opportunistic infection in HIV patients. MORU’s Clinical Pharmacology conducts two trials on possible treatments of hepatitis C. Hepatitis B is frequently transmitted from mother to child at birth, and SMRU researchers study mothers’ knowledge and behaviour, as well as prevention.

Incomplete reporting of COVID-19 disease severity criteria compromises meta-analysis

Patients affected by COVID-19 should be treated according to the severity of their disease. However, not all key national or international organisations define severity in the same way. This imprecision in severity assessment compromises the validity of some therapeutic recommendations. Using individual patient data would better guide and improve therapeutic recommendations for COVID-19.

Field evaluation of EasyScan GO: a digital malaria microscopy device

Microscopic examination of Giemsa-stained blood films is key to quantifying and detecting malaria parasites but there can be difficulties in ensuring both a high-quality manual reading and inter-reader reliability. The EasyScan GO was developed as a potential solution to this, a microscopy device using machine-learning-based image analysis for automated parasite detection and quantification.

Congratulations to Professor Sir David Warrell, appointed Knight Commander of the Order of St Michael and St George!

David Warrell, MORU founding director, has been appointed by the Queen ‘Knight Commander of the Order of St Michael and St George for services to global Health Research and Clinical Practice’. Please join us in congratulating Sir David on receiving this richly deserved high honour!

Laos’ first Pint of Science: warty newts, COVID, AI for Instagram, and more!

Organised by a grass-root community of thousands of scientists across the world, Pint of Science 2022 allows researchers in 25 countries and over 800 cities to share their latest findings with lay folk in interesting, informal settings. Lao PDR joined the global Pint of Science family on Monday 9 May, when the first-ever Pint of Science Laos kicked off!

Patient recruitment on track in Oxford-led DeTACT trial of safe, effective drug combinations to prevent the spread of artemisinin and multi-drug resistant malaria in Africa

Today is World Malaria Day. The global fight against malaria is at a critical point. No new antimalarial drugs are expected in the near future, and if multi-drug resistant falciparum malaria becomes established in East Africa and spreads to other parts of Africa, millions will be at risk of drug-resistant malaria infection and death. The development of triple artemisinin-based combination therapies aims to prevent or delay the emergence of artemisinin and multi-drug resistant malaria in Africa.